跳至主要内容
临床试验/ISRCTN16378480
ISRCTN16378480已完成未知

Effectiveness of a chatbot in improving the mental wellbeing of health workers in Malawi during the COVID-19 pandemic: A randomized, controlled trial

Chemonics International0 个研究点目标入组 1,584 人开始时间: 2022年5月12日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,584

研究概览

简要总结

2024 Results article in https://doi.org/10.1371/journal.pone.0303370 (added 29/05/2024)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Currently employed as one of the types of service providers (cadres) listed: doctors, nurses, medical assistants, clinical officers, laboratory technicians, physiotherapy technicians, pharmacists, physiotherapists
  • 2. Employed in public or private primary, secondary, or tertiary care facility in Blantyre and Lilongwe districts of Malawi
  • 3. Possess some degree of English language proficiency
  • 4. Own a smartphone with an Android operating system
  • 5. No history – past or current – of counseling or therapy for severe mental health disorders
  • 6. Not have self-reported suicidal ideation
  • 7. Score below very high risk” levels on the initial assessments for anxiety and depression
  • 8. Diploma in their respective fields of specialization, in adherence to the Ministry of Health employment criteria for the respective cadres of health workers (Medical Assistants who completed 2 years of college will be allowed to participate even though their qualification is a certificate)
  • 9. Adults (18 years or older)

排除标准

  • 1. All other hospital- or health-related personnel, such as health surveillance assistants, hospital assistants or laboratory assistants, due to their lower educational qualification requirement for employment.
  • 2. Health workers with a history – past or current – of counseling or therapy for a severe mental disorder
  • 3. All study applicants at very high risk” of depression and anxiety according to their initial scores from standard mental health tests
  • 4. Participants who check suicidal ideation in question nine of the PHQ-9

研究者

发起方
Chemonics International

相似试验